A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Staar Surgical CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 44,538 shares of STAA stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,538
Previous 52,173 14.63%
Holding current value
$1.85 Million
Previous $1.63 Million 4.67%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$27.67 - $39.61 $211,260 - $302,422
-7,635 Reduced 14.63%
44,538 $1.7 Million
Q4 2023

Feb 14, 2024

SELL
$30.6 - $43.78 $178,061 - $254,755
-5,819 Reduced 10.03%
52,173 $1.63 Million
Q3 2023

Nov 13, 2023

BUY
$39.39 - $58.12 $1.65 Million - $2.44 Million
41,949 Added 261.48%
57,992 $2.33 Million
Q2 2023

Aug 11, 2023

SELL
$50.45 - $72.82 $62,103 - $89,641
-1,231 Reduced 7.13%
16,043 $843,000
Q1 2023

May 12, 2023

SELL
$51.25 - $79.34 $2.01 Million - $3.12 Million
-39,316 Reduced 69.48%
17,274 $1.1 Million
Q4 2022

Feb 13, 2023

SELL
$46.82 - $76.2 $893,981 - $1.45 Million
-19,094 Reduced 25.23%
56,590 $2.75 Million
Q3 2022

Nov 10, 2022

BUY
$70.55 - $111.58 $13,686 - $21,646
194 Added 0.26%
75,684 $5.34 Million
Q2 2022

Aug 11, 2022

BUY
$50.24 - $80.48 $344,847 - $552,414
6,864 Added 10.0%
75,490 $5.36 Million
Q1 2022

May 13, 2022

BUY
$57.98 - $93.5 $958,641 - $1.55 Million
16,534 Added 31.74%
68,626 $5.48 Million
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $771,319 - $1.12 Million
8,763 Added 20.22%
52,092 $4.76 Million
Q3 2021

Nov 12, 2021

SELL
$122.75 - $162.68 $408,021 - $540,748
-3,324 Reduced 7.12%
43,329 $5.57 Million
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $4.93 Million - $7.23 Million
46,653 New
46,653 $7.12 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $2B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.